Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Terns Pharmaceuticals (TERN) Other Gross PP&E Adjustments (2020 - 2025)

Terns Pharmaceuticals filings provide 6 years of Other Gross PP&E Adjustments readings, the most recent being -$3.5 million for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 10.16% to -$3.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.5 million through Dec 2025, up 10.16% year-over-year, with the annual reading at -$3.5 million for FY2025, 10.16% up from the prior year.
  • Other Gross PP&E Adjustments hit -$3.5 million in Q4 2025 for Terns Pharmaceuticals, down from -$2.2 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $649000.0 in Q4 2021 and bottomed at -$3.9 million in Q4 2024.
  • Average Other Gross PP&E Adjustments over 5 years is -$2.2 million, with a median of -$2.4 million recorded in 2022.
  • The largest annual shift saw Other Gross PP&E Adjustments soared 302.18% in 2021 before it tumbled 475.5% in 2022.
  • Terns Pharmaceuticals' Other Gross PP&E Adjustments stood at $649000.0 in 2021, then tumbled by 475.5% to -$2.4 million in 2022, then increased by 12.27% to -$2.1 million in 2023, then tumbled by 83.21% to -$3.9 million in 2024, then rose by 10.16% to -$3.5 million in 2025.
  • Per Business Quant, the three most recent readings for TERN's Other Gross PP&E Adjustments are -$3.5 million (Q4 2025), -$2.2 million (Q3 2025), and -$2.5 million (Q2 2025).